Business Wire

Asuragen to Present at 2019 European Society of Human Genetics (ESHG) Conference

Share

Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, will host a corporate satellite meeting and its AmplideX® technology will be featured in multiple scientific posters at the upcoming European Society of Human Genetics (ESHG) Conference in Gothenburg, Sweden on June 15-18.

The corporate satellite, “Shining a Light on Dark DNA: Simple and Streamlined Solutions for SMN1/2 Copy Number Determination, HTT Expansions, and More…,” will showcase the newest additions to the AmplideX family of products. Márcia Oliveira, PhD, ErCLG, Centro Hospitalar do Porto E.P.E. Centro de Genetica Medica Doutar Jacinto de Magalhaes in Porto, Portugal, will share her laboratory’s experience in evaluating the AmplideX PCR/CE SMN1/2 Kit*, which determines the copy number for both SMN1 and SMN2 in a single PCR reaction in less than four hours. Additionally, Ferdinando Squitieri, MD, PhD, Head of Neurology CSS-Mendel Institute of Human Genetics and Head of Huntington and Rare Diseases Unit IRCCS in Rome, Italy, will review both the clinical and laboratory perspectives on Huntington’s disease and how the AmplideX PCR/CE HTT Kit* streamlines the detection and sizing of CAG trinucleotide expansions in the HTT gene. The symposium will occur on Sunday, June 16, from 11:15-12:45 at the Swedish Exhibition & Congress Center in Gothenburg in Room A2.

Four posters will be presented at the meeting highlighting Asuragen’s latest developments within the rapidly growing AmplideX product portfolio and continued efforts supporting the genetics research community.

Two posters will be presented during the Group B poster session from 16:45-17:45 on Sunday, June 16.

  • P10.35B: Accurate single-tube quantification of SMN1 and SMN2 copy numbers using a rapid and streamlined PCR/CE assay evaluated at two different laboratories (Márcia Oliveira, PhD, ErCLG)
  • P14.039B: Analytical validation of a sensitive myotonic dystrophy type 1 (DM1) diagnostic test that provides precise repeat sizing and resolves zygosity in a single PCR (Gary Latham, PhD)

Two additional posters will be presented during the Group D poster session from 16:45-17:45 on Monday, June 17.

  • P09.061D: A novel repeat-primed PCR assay to detect the full range of trinucleotide CAG repeats in Huntingtin gene (HTT) (Ferdinando Squitieri, MD, PhD)
  • P01.28D: Absence of AGG interruptions is a risk factor for a full mutation expansion among ethnically diverse FMR1 premutation carriers (Noam Domniz, MD)

“AmplideX technology continues to revolutionize the detection and interpretation of genomic targets implicated in a broad spectrum of neurodegenerative and neurodevelopmental disorders,” said Matthew McManus, MD, PhD, president and CEO of Asuragen. “Our rapidly expanding genetics product portfolio featuring simple and streamlined testing workflows makes analysis of these important targets practical for laboratories everywhere.”

The company will also have a presence at stand #274 during the conference.

* For Research Use Only. Not for use in diagnostic procedures.

About Asuragen

Asuragen is a molecular diagnostic product company changing the way patients are treated in genetics and oncology. Asuragen’s diagnostic systems, composed of proprietary chemistry and software, deliver powerful answers using broadly installed instrument platforms. They are simple to adopt and expand the ability to serve patients. Asuragen is a product foundry rapidly and efficiently addressing current and emerging clinical needs, including cancer diagnosis and monitoring, reproductive health and aging, serving laboratories across a patient’s lifespan with its best in class diagnostic tests. For more information, visit www.asuragen.com.

Contact information

Asuragen, Inc.
Lynne Hohlfeld
SVP, Corporate Development and CFO
T: 512.681.5200
lhohlfeld@asuragen.com
www.asuragen.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

To Help Building and Facilities Managers Meet the Demands of Social Distancing, Bentley Systems Opens Up Full Access to LEGION Simulator and OpenBuildings Station Designer and Waives Subscription Fees through September 304.6.2020 18:03:00 CESTPress release

Bentley Systems, Incorporated, a leading global provider of comprehensive software and digital twins services for advancing the design, construction, and operations of infrastructure, today announced it has opened up its LEGIONSimulator and OpenBuildings Station Designer software, including waiving new subscription fees through September 30, 2020, for facilities managers to incorporate pedestrian simulation methodologies across their planning, design, and operations teams. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200604005622/en/ Top left illustrates a 3D model of a retail operation created using OpenBuildings Station Designer. Bottom left shows 2D floor plans that are then imported into LEGION Simulator (right) to test two scenarios. Examples shown are at occupancy rates of 75% (top) and 25% (bottom) to comply with social distancing requirements. (Photo: Business Wire) With social distancing and crowd management at th

European Commission Grants Marketing Authorisation for DARZALEX ® ▼ (daratumumab) Subcutaneous Formulation for all Currently Approved Daratumumab Intravenous Formulation Indications4.6.2020 16:00:00 CESTPress release

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission (EC) has granted marketing authorisation for DARZALEX®▼(daratumumab) subcutaneous (SC) formulation for the treatment of adult patients with multiple myeloma (MM). Daratumumab SC is administered as a fixed dose, which significantly reduces treatment time, from hours to approximately three to five minutes, when compared to daratumumab intravenous (IV) formulation.1 In addition, only the first dose of daratumumab SC needs to be administered in an environment where resuscitation facilities are available. The approval applies to all current daratumumab indications in frontline and relapsed/refractory settings, and patients currently on daratumumab IV can switch to the SC formulation should they choose to. Data supporting the approval show that daratumumab SC demonstrated a consistent overall response rate (ORR) and a similar safety profile compared with daratumumab IV in patients with rela

HCL and Google Cloud Expand Partnership to Digitally Transform Commerce4.6.2020 16:00:00 CESTPress release

HCL Technologies (HCL), a leading global technology company, and Google Cloud today announced the expansion of their strategic partnership to bring HCL's software offerings, starting with HCL Commerce, to Google Cloud. Google Cloud will be the preferred cloud platform for HCL Commerce, providing global, secure and elastic infrastructure to power businesses’ eCommerce strategies. Under this partnership, HCL also intends to leverage Anthos to enable multi-cloud and hybrid-cloud deployments of HCL Commerce. HCL Commerce is a leading, cloud-native Commerce platform used by innovative businesses across multiple industries and around the world to drive more than $100 billion in annual client revenues. With a strong track-record of delivering rock-solid performance, scalability and functionality, HCL Commerce today is at the forefront of many organizations’ digital commerce strategies. It stretches far beyond an initial transaction and enables businesses to respond to evolving market conditio

AT&T ® México Selects MATRIXX Software for Prepaid Platform Replacement4.6.2020 15:00:00 CESTPress release

MATRIXX Software today announced that https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.att.com.mx&esheet=52230127&newsitemid=20200604005138&lan=en-US&anchor=AT%26amp%3BT%26%23174%3B+M%26eacute%3Bxico&index=2&md5=52456f1fe4eebcb68026fb5ad3b2dd58 AT&T® México, a subsidiary of AT&T® USA and one of the largest mobile players in the Mexican market, is deploying MATRIXX Software’s cloud native digital commerce platform for its prepaid customers. MATRIXX Digital Commerce is replacing multiple legacy Intelligent Network (IN) and Business Support Systems (BSS) to provide a future-proof, web-scale BSS that will allow for greater innovation and business agility. MATRIXX will support both the AT&T brand and UNEFON brand on a single platform. The industry’s leading solution for real-time cloud native rating and convergent charging for 5G(CCS) and 4G(OCS), MATRIXX Digital Commerce was selected after a rigorous evaluation process that included multiple vendors. “We are proud to be

Moody’s Analytics Forecast: Resurgence of COVID-19 Could Cause Global Economic Depression4.6.2020 14:00:00 CESTPress release

According to the Moody’s Analytics baseline economic forecast, real global GDP will fall by 4.5% this year as a result of COVID-19. Our base case for the US suggests that it will take until mid-decade for the economy to return to full-employment. Mark Zandi, Chief Economist at Moody’s Analytics, describes the outlook in a new paper, Handicapping the Paths for the Pandemic Economy. “COVID-19 has caused massive damage to the global economy. Quickly reopening economies will boost growth by unleashing pent-up demand, but will also raise the specter of a re-intensification of COVID-19 and another economic downdraft, which could lead to a worldwide depression. We construct our economic forecasts to help market participants navigate this daunting uncertainty and make better decisions,” said Mr. Zandi. The Moody’s Analytics baseline economic forecast represents our view of the most likely trajectory for the global economy. The baseline forecast is part of a set of 12 forecast scenarios, update

Vertex Enhances Integrated Tax Solution for SAP ® Ariba ®4.6.2020 13:13:00 CESTPress release

Vertex, Inc.,a leading provider of tax technology and services, announced enhancements to its solutions integration with SAP® Ariba® Buying and Invoicing, providing customers with timely, advanced tax insights within their procurement and supply chain processes. Vertex launched an SAP Ariba Tax API and the Vertex Indirect Tax for Procurement with SAP Ariba app extension in 2018, enabling companies to obtain tax calculations from within SAP Ariba Buying and Invoicing, while also supporting the requisition and invoice reconciliation phases of the tax process. This integration with SAP Ariba solutions helps calculate tax at the purchase requisition, invoice reconciliation and final tax determination phases, carrying tax from the purchase requisition to the purchase order. The integrated solution is now enhanced to distinguish between vendor charged, buyer payable, self-assessed and value-added reverse charge taxes, as well as multiple levels of jurisdictions. SAP Ariba solutions provide c